ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 32 filers reported holding ELEVATION ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,262,459 | -20.0% | 830,565 | 0.0% | 0.22% | -31.9% |
| Q1 2023 | $1,578,074 | +100.0% | 830,565 | 0.0% | 0.33% | +91.8% |
| Q4 2022 | $789,037 | -16.0% | 830,565 | 0.0% | 0.17% | -22.4% |
| Q3 2022 | $939,000 | -19.3% | 830,565 | 0.0% | 0.22% | -29.4% |
| Q2 2022 | $1,163,000 | -50.5% | 830,565 | -10.9% | 0.31% | -47.5% |
| Q1 2022 | $2,349,000 | -58.1% | 932,240 | 0.0% | 0.59% | -45.7% |
| Q4 2021 | $5,612,000 | -22.7% | 932,240 | 0.0% | 1.09% | -4.4% |
| Q3 2021 | $7,262,000 | -42.6% | 932,240 | +0.0% | 1.14% | -27.1% |
| Q2 2021 | $12,650,000 | – | 932,239 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $38,470,000 | 6.16% |
| venBio Partners LLC | 2,608,167 | $35,393,000 | 4.18% |
| Samsara BioCapital, LLC | 932,239 | $12,650,000 | 1.56% |
| Cormorant Asset Management, LP | 1,983,165 | $25,566,000 | 0.87% |
| BVF INC/IL | 1,590,291 | $21,580,000 | 0.81% |
| Boxer Capital, LLC | 1,341,530 | $18,205,000 | 0.64% |
| Ghost Tree Capital, LLC | 100,000 | $1,357,000 | 0.37% |
| CAXTON CORP | 39,586 | $537,000 | 0.37% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,999,514 | $26,456,000 | 0.35% |
| Vivo Capital, LLC | 496,843 | $6,742,000 | 0.29% |